News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Pfizer Inc. Executive, Martin Mackay Jumps Ship to Head AstraZeneca PLC’s R&D
May 26, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- AstraZeneca Plc said on Wednesday it had appointed Martin Mackay from Pfizer Inc (PFE.N) as its global head of research and development, while Pfizer named Mikael Dolsten as its new R&D leader.
Twitter
LinkedIn
Facebook
Email
Print
People
AstraZeneca
Pfizer
MORE ON THIS TOPIC
Insights
After COVID, biomanufacturing tackles preparedness and commercialization challenges
September 25, 2026
·
4 min read
·
Jennifer C. Smith-Parker
Legal
Nektar prevails in legal battle with Lilly over broken rezpeg partnership
September 25, 2026
·
2 min read
·
Annalee Armstrong
IPO
ADARx raises $446M in biotech’s third largest IPO of 2026, City files to go public
September 25, 2026
·
2 min read
·
Gabrielle Masson
Artificial intelligence
Genentech makes $1.5B+ deal with AI heavyweight Earendil for cancer bispecifics
September 25, 2026
·
2 min read
·
Tristan Manalac
